Search results
Results from the WOW.Com Content Network
Lipodystrophy syndromes are a group of genetic or acquired disorders in which the body is unable to produce and maintain healthy fat tissue. [ 1 ] [ 2 ] The medical condition is characterized by abnormal or degenerative conditions of the body's adipose tissue .
Metreleptin, sold under the brand name Myalept among others, is a synthetic analog of the hormone leptin used to treat various forms of dyslipidemia.It has been approved in Japan for metabolic disorders including lipodystrophy and in the United States as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired ...
First edition (publ. Flatiron Books) How Not to Die: Discover the Foods Scientifically Proven to Prevent and Reverse Disease is a book by Michael Greger, M.D. with Gene Stone, published in 2015 that argues for the health benefits of a whole food plant-based diet. [1]
GLP-1 Diet Plan. GLP-1 medications — that’s glucagon-like peptide-1 receptor agonists — are prescribed alongside diet and exercise to help people lose weight or manage type 2 diabetes. But ...
Reverse dieting trains your metabolism post-diet to prevent weight gain. It involves adding back 50 to 100 calories of protein per day in weekly steps to maintain weight.
Acquired generalized lipodystrophy (AGL), also known as Lawrence syndrome [1] and Lawrence–Seip syndrome, [1] is a rare skin condition that appears during childhood or adolescence, characterized by fat loss affecting large areas of the body, particularly the face, arms, and legs.
“It’s called reverse dieting, and while it’s been around for some time in the bodybuilding community, it’s relatively new to the mainstream world,” says Mir Ali, MD, a bariatric surgeon ...
Congenital generalized lipodystrophy (also known as Berardinelli–Seip lipodystrophy) is an extremely rare autosomal recessive condition, characterized by an extreme scarcity of fat in the subcutaneous tissues. [2] It is a type of lipodystrophy disorder where the magnitude of fat loss determines the severity of metabolic complications. [3]